A detailed history of Perkins Capital Management Inc transactions in Natera, Inc. stock. As of the latest transaction made, Perkins Capital Management Inc holds 54,350 shares of NTRA stock, worth $9.09 Million. This represents 6.8% of its overall portfolio holdings.

Number of Shares
54,350
Previous 57,550 5.56%
Holding current value
$9.09 Million
Previous $6.23 Million 10.83%
% of portfolio
6.8%
Previous 6.14%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$97.75 - $129.67 $312,800 - $414,943
-3,200 Reduced 5.56%
54,350 $6.91 Million
Q2 2024

Aug 09, 2024

SELL
$85.28 - $112.6 $219,596 - $289,945
-2,575 Reduced 4.28%
57,550 $6.23 Million
Q1 2024

May 09, 2024

SELL
$59.21 - $92.9 $103,617 - $162,575
-1,750 Reduced 2.83%
60,125 $5.5 Million
Q4 2023

Jan 22, 2024

SELL
$37.55 - $62.64 $1,877 - $3,132
-50 Reduced 0.08%
61,875 $3.88 Million
Q3 2023

Nov 02, 2023

SELL
$43.4 - $62.52 $11,935 - $17,193
-275 Reduced 0.44%
61,925 $2.74 Million
Q2 2023

Jul 21, 2023

SELL
$47.08 - $55.16 $23,540 - $27,580
-500 Reduced 0.8%
62,200 $3.03 Million
Q1 2023

May 09, 2023

BUY
$36.57 - $58.29 $29,256 - $46,632
800 Added 1.29%
62,700 $3.48 Million
Q4 2022

Jan 26, 2023

SELL
$34.17 - $47.91 $5,125 - $7,186
-150 Reduced 0.24%
61,900 $2.49 Million
Q3 2022

Oct 24, 2022

SELL
$36.93 - $56.68 $97,864 - $150,202
-2,650 Reduced 4.1%
62,050 $2.72 Million
Q2 2022

Jul 29, 2022

BUY
$28.13 - $44.54 $177,219 - $280,602
6,300 Added 10.79%
64,700 $2.29 Million
Q1 2022

Apr 20, 2022

SELL
$30.32 - $91.33 $54,576 - $164,394
-1,800 Reduced 2.99%
58,400 $2.38 Million
Q4 2021

Feb 10, 2022

SELL
$86.26 - $119.0 $189,772 - $261,800
-2,200 Reduced 3.53%
60,200 $5.62 Million
Q3 2021

Oct 25, 2021

SELL
$100.17 - $126.36 $5,008 - $6,318
-50 Reduced 0.08%
62,400 $6.95 Million
Q2 2021

Jul 28, 2021

SELL
$86.05 - $119.72 $129,075 - $179,580
-1,500 Reduced 2.35%
62,450 $7.09 Million
Q1 2021

Apr 28, 2021

SELL
$91.47 - $124.36 $192,087 - $261,156
-2,100 Reduced 3.18%
63,950 $6.49 Million
Q4 2020

Feb 09, 2021

SELL
$66.66 - $111.74 $309,969 - $519,591
-4,650 Reduced 6.58%
66,050 $6.57 Million
Q3 2020

Oct 28, 2020

SELL
$45.89 - $72.67 $144,553 - $228,910
-3,150 Reduced 4.27%
70,700 $5.11 Million
Q1 2020

Apr 29, 2020

SELL
$17.27 - $40.17 $139,023 - $323,368
-8,050 Reduced 9.83%
73,850 $2.21 Million
Q4 2019

Feb 03, 2020

SELL
$32.1 - $40.4 $866,700 - $1.09 Million
-27,000 Reduced 24.79%
81,900 $2.76 Million
Q3 2019

Oct 23, 2019

SELL
$25.38 - $34.89 $446,688 - $614,064
-17,600 Reduced 13.91%
108,900 $3.57 Million
Q2 2019

Aug 09, 2019

SELL
$17.75 - $27.58 $60,350 - $93,772
-3,400 Reduced 2.62%
126,500 $3.49 Million
Q1 2019

Apr 22, 2019

BUY
$11.34 - $20.62 $807,408 - $1.47 Million
71,200 Added 121.29%
129,900 $2.68 Million
Q4 2018

Feb 11, 2019

SELL
$12.32 - $24.38 $71,456 - $141,404
-5,800 Reduced 8.99%
58,700 $819,000
Q3 2018

Oct 22, 2018

BUY
$18.82 - $28.96 $732,098 - $1.13 Million
38,900 Added 151.95%
64,500 $1.54 Million
Q2 2018

Aug 02, 2018

BUY
$8.79 - $19.98 $225,023 - $511,488
25,600 New
25,600 $482,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Perkins Capital Management Inc Portfolio

Follow Perkins Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.